H.R.1996 - SAFE Banking Act of 2021 Cannabis Administration & Opportunity Act Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement. FDA regulation of cannabis-derived products
PHA - Pharmacy
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
JAZZ PHARMACEUTICALS, INC.
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815, Sausalito, CA, 94965, US
VIRGINIA MCMILLIN KARAS GROSS (FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08))
FDA - Associate Commissioner for Legislative Affairs (2019-20); House Rules Committee - Deputy Staff Director (2011-19); House Judiciary Committee - Deputy Parliamentarian (2008-11); House of Representatives - Sr. Legislative Assistant (2004-08)